Weybosset Research & Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11M | Buy |
39,439
+682
| +2% | +$179K | 2.9% | 17 |
|
|
2026
Q1 | $10.3M | Buy |
38,757
+427
| +1% | +$116K | 2.98% | 17 |
|
|
2025
Q4 | $9.62M | Sell |
38,330
-385
| -1% | -$102K | 2.97% | 18 |
|
|
2025
Q3 | $11.1M | Sell |
38,715
-280
| -0.7% | -$75K | 3.59% | 14 |
|
|
2025
Q2 | $10.2M | Sell |
38,995
-205
| -0.5% | -$49.9K | 3.52% | 15 |
|
|
2025
Q1 | $9.12M | Sell |
39,200
-218
| -0.6% | -$52.9K | 3.19% | 15 |
|
|
2024
Q4 | $9.04M | Sell |
39,418
-29
| -0.1% | -$6.65K | 3.08% | 16 |
|
|
2024
Q3 | $8.82M | Buy |
+39,447
| New | +$8.67M | 2.98% | 19 |
|
|
2024
Q2 | – | Sell |
-39,149
| Closed | -$233 | – | 52 |
|
|
2024
Q1 | $233 | Sell |
39,149
-613
| -2% | -$135K | 0.08% | 39 |
|
|
2023
Q4 | $9.04M | Buy |
39,762
+224
| +0.6% | +$47.1K | 3.2% | 16 |
|
|
2023
Q3 | $7.95M | Sell |
39,538
-6,520
| -14% | -$1.38M | 3.17% | 17 |
|
|
2023
Q2 | $9.55M | Buy |
46,058
+312
| +0.7% | +$60.5K | 3.5% | 16 |
|
|
2023
Q1 | $9.02M | Sell |
45,746
-188
| -0.4% | -$38.7K | 3.4% | 15 |
|
|
2022
Q4 | $9.29M | Sell |
45,934
-171
| -0.4% | -$33.4K | 3.59% | 16 |
|
|
2022
Q3 | $8.11M | Buy |
46,105
+1,274
| +3% | +$261K | 3.57% | 15 |
|
|
2022
Q2 | $9.03M | Buy |
+44,831
| New | +$9.56M | 4.46% | 13 |
|
|
2021
Q4 | $12M | Sell |
44,355
-254
| -0.6% | -$62.9K | 4.46% | 7 |
|
|
2021
Q3 | $10.8M | Sell |
44,609
-204
| -0.5% | -$51.4K | 4.38% | 7 |
|
|
2021
Q2 | $10.6M | Sell |
44,813
-875
| -2% | -$199K | 4.32% | 7 |
|
|
2021
Q1 | $10M | Buy |
45,688
+1,270
| +3% | +$255K | 4.13% | 12 |
|
|
2020
Q4 | $7.77M | Buy |
44,418
+903
| +2% | +$156K | 3.57% | 15 |
|
|
2020
Q3 | $7.04M | Sell |
43,515
-314
| -0.7% | -$49.8K | 3.86% | 14 |
|
|
2020
Q2 | $6.25M | Sell |
43,829
-15
| -0% | -$2.08K | 3.66% | 15 |
|
|
2020
Q1 | $4.42M | Sell |
43,844
-1,849
| -4% | -$266K | 3.15% | 16 |
|
|
2019
Q4 | $6.64M | Sell |
45,693
-81
| -0.2% | -$11.7K | 3.47% | 16 |
|
|
2019
Q3 | $6.61M | Buy |
45,774
+99
| +0.2% | +$14.4K | 3.78% | 14 |
|
|
2019
Q2 | $6.79M | Buy |
45,675
+330
| +0.7% | +$46K | 3.94% | 12 |
|
|
2019
Q1 | $5.96M | Buy |
45,345
+12,554
| +38% | +$1.55M | 3.5% | 16 |
|
|
2018
Q4 | $3.56M | Buy |
32,791
+294
| +0.9% | +$39.4K | 2.43% | 19 |
|
|
2018
Q3 | $4.85M | Buy |
32,497
+757
| +2% | +$115K | 2.79% | 17 |
|
|
2018
Q2 | $4.89M | Sell |
31,740
-239
| -0.7% | -$36.1K | 2.96% | 18 |
|
|
2018
Q1 | $4.44M | Buy |
31,979
+638
| +2% | +$93.7K | 2.67% | 20 |
|
|
2017
Q4 | $4.29M | Sell |
31,341
-17
| -0.1% | -$2.25K | 2.61% | 20 |
|
|
2017
Q3 | $4.07M | Sell |
31,358
-788
| -2% | -$105K | 2.7% | 19 |
|
|
2017
Q2 | $4.26M | Buy |
32,146
+122
| +0.4% | +$14.9K | 2.74% | 19 |
|
|
2017
Q1 | $3.95M | Buy |
32,024
+1,787
| +6% | +$212K | 2.67% | 17 |
|
|
2016
Q4 | $3.33M | Buy |
30,237
+1,722
| +6% | +$191K | 2.34% | 19 |
|
|
2016
Q3 | $3.37M | Buy |
28,515
+34
| +0.1% | +$4.01K | 2.44% | 19 |
|
|
2016
Q2 | $3.19M | Buy |
28,481
+2,632
| +10% | +$283K | 2.43% | 18 |
|
|
2016
Q1 | $2.6M | Buy |
25,849
+240
| +0.9% | +$23K | 2.2% | 20 |
|
|
2015
Q4 | $2.72M | Sell |
25,609
-4,153
| -14% | -$428K | 2.41% | 18 |
|
|
2015
Q3 | $2.77M | Sell |
29,762
-63
| -0.2% | -$6.52K | 2.07% | 19 |
|
|
2015
Q2 | $3.11M | Sell |
29,825
-721
| -2% | -$75K | 2.05% | 19 |
|
|
2015
Q1 | $3.31M | Buy |
+30,546
| New | +$3.14M | 2.09% | 21 |
|
Other funds holding LH
Weybosset Research & Management's LH Position: Q2 2026 in Review
Weybosset Research & Management increased its Labcorp (LH) stake by 1.8% in Q2 2026, buying an estimated $179K and bringing the position to 39,439 shares worth $11M. The position accounts for 2.9% of the portfolio, ranked #17.
Weybosset Research & Management first reported a position in LH in Q1 2015 and has held it in 44 quarters since. The position peaked at $12M in Q4 2021. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Weybosset Research & Management held 39,439 shares of Labcorp worth $11M as of Q2 2026.
- Weybosset Research & Management bought 682 Labcorp shares in Q2 2026, an estimated $179K.
- Labcorp made up 2.9% of Weybosset Research & Management's portfolio in Q2 2026, its #17 holding.
- Weybosset Research & Management first reported a position in Labcorp in Q1 2015 and has held it in 44 quarters since.
- Weybosset Research & Management's Labcorp position peaked at $12M in Q4 2021.
- 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Weybosset Research & Management's 13F filing for Q2 2026, filed 28 Jul 2026.